4.2 Article

Development of innate immune cells from human pluripotent stem cells

Journal

EXPERIMENTAL HEMATOLOGY
Volume 71, Issue -, Pages 13-23

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.exphem.2018.12.005

Keywords

-

Funding

  1. National Institutes of Health/National Cancer Institute [R01 CA203348, U01 CA217885]
  2. California Institute for Regenerative Medicine [CIRM DISC2-09615, CIRM TRAN1-10587]
  3. Takeda-Sanford Innovation Alliance
  4. Fate Therapeutics

Ask authors/readers for more resources

Mouse and human pluripotent stem cells have been widely used to study the development of the hematopoietic and immune systems. Although not all cells can be derived with the same efficiency, immune cells such as natural killer (NK) cells and macrophages can be easily produced from PSCs to enable development of new cell-based therapies. NK cells and macrophages are part of the innate immune system, the first line of defense against malignancies and infectious disease. Human embryonic stem cell (hESC)- and induced pluripotent stem cell (iPSC)-derived NK cells can be produced at a clinical scale suitable for translation into clinical trials. Additionally, PSCs can be genetically modified to produce hESC/iPSC-derived human NK cells with enhanced antitumor activity. These engineered NK cells can express a stabilized version of the high-affinity Fc receptor CD16, chimeric antigen receptors, or other strategies to enable more potent and targeted cellular immunotherapies. Moreover, macrophages can also be routinely and efficiently produced from hESCs and iPSCs as a tool to expand our knowledge of the basic biology of these cells. hESC- and iPSC-derived macrophages can also be employed as a novel approach for cancer immunotherapy, as well as a strategy to repair or regenerate diseased and damaged tissues and organs. (C) 2019 ISEH - Society for Hematology and Stem Cells. Published by Elsevier Inc. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Cell & Tissue Engineering

Single Cell Resolution of Human Hematoendothelial Cells Defines Transcriptional Signatures of Hemogenic Endothelium

Mathew G. Angelos, Juan E. Abrahante, Robert H. Blum, Dan S. Kaufman

STEM CELLS (2018)

Article Cell & Tissue Engineering

Human iPSC-Derived Natural Killer Cells Engineered with Chimeric Antigen Receptors Enhance Anti-tumor Activity

Ye Li, David L. Hermanson, Branden S. Moriarity, Dan S. Kaufman

CELL STEM CELL (2018)

Review Hematology

Advances in the role of the aryl hydrocarbon receptor to regulate early hematopoietic development

Mathew G. Angelos, Dan S. Kaufman

CURRENT OPINION IN HEMATOLOGY (2018)

Review Immunology

Off-the-shelf cell therapy with induced pluripotent stem cell-derived natural killer cells

Michelle L. Saetersmoen, Quirin Hammer, Bahram Valamehr, Dan S. Kaufman, Karl-Johan Malmberg

SEMINARS IN IMMUNOPATHOLOGY (2019)

Review Clinical Neurology

Outcomes and Cost-Effectiveness of Autologous Hematopoietic Cell Transplant for Multiple Sclerosis

Anastasie M. Dunn-Pirio, Benjamin M. Heyman, Dan S. Kaufman, Revere P. Kinkel

CURRENT TREATMENT OPTIONS IN NEUROLOGY (2019)

Article Hematology

Pluripotent stem cell-derived NK cells with high-affinity noncleavable CD16a mediate improved antitumor activity

Huang Zhu, Robert H. Blum, Ryan Bjordahl, Svetlana Gaidarova, Paul Rogers, Tom Tong Lee, Ramzey Abujarour, Gregory B. Bonello, Jianming Wu, Pei-Fang Tsai, Jeffrey S. Miller, Bruce Walcheck, Bahram Valamehr, Dan S. Kaufman

BLOOD (2020)

Article Cell & Tissue Engineering

Lineage-specific differentiation of osteogenic progenitors from pluripotent stem cells reveals theFGF1-RUNX2association in neural crest-derived osteoprogenitors

Fahad Kidwai, Byron W. H. Mui, Deepika Arora, Kulsum Iqbal, Madison Hockaday, Luis Fernandez de Castro Diaz, Natasha Cherman, Daniel Martin, Vamsee D. Myneni, Moaz Ahmad, Katarzyna Futrega, Sania Ali, Randall K. Merling, Dan S. Kaufman, Janice Lee, Pamela G. Robey

STEM CELLS (2020)

Article Cell & Tissue Engineering

Metabolic Reprograming via Deletion of CISH in Human iPSC-Derived NK Cells Promotes In Vivo Persistence and Enhances Anti-tumor Activity

Huang Zhu, Robert H. Blum, Davide Bernareggi, Eivind Heggernes Ask, Zhengming Wu, Hanna Julie Hoel, Zhipeng Meng, Chengsheng Wu, Kun-Liang Guan, Karl-Johan Malmberg, Dan S. Kaufman

CELL STEM CELL (2020)

Article Immunology

Umbilical Cord Blood and iPSC-Derived Natural Killer Cells Demonstrate Key Differences in Cytotoxic Activity and KIR Profiles

Benjamin H. Goldenson, Huang Zhu, YunZu Michele Wang, Naveen Heragu, Davide Bernareggi, Alessa Ruiz-Cisneros, Andres Bahena, Eivind Heggernes Ask, Hanna Julie Hoel, Karl-Johan Malmberg, Dan S. Kaufman

FRONTIERS IN IMMUNOLOGY (2020)

Review Biochemistry & Molecular Biology

An expanded universe of cancer targets

William C. Hahn, Joel S. Bader, Theodore P. Braun, Andrea Califano, Paul A. Clemons, Brian J. Druker, Andrew J. Ewald, Haian Fu, Subhashini Jagu, Christopher J. Kemp, William Kim, Calvin J. Kuo, Michael McManus, Gordon B. Mills, Xiulei Mo, Nidhi Sahni, Stuart L. Schreiber, Jessica A. Talamas, Pablo Tamayo, Jeffrey W. Tyner, Bridget K. Wagner, William A. Weiss, Daniela S. Gerhard

Summary: Characterization of cancer genomes has provided insight into somatically altered genes across tumors, but the function of most cancer alleles remains mysterious and does not impact therapy for most patients. Approaches to understand the function and circuitry of cancer genes provide complementary approaches to elucidate both oncogene and non-oncogene dependencies. Emerging work indicates that therapeutic targets engendered by non-oncogene dependencies are more diverse than recurrently mutated genes, providing new opportunities for clinical translation.
Editorial Material Cell & Tissue Engineering

Into the multiverse of gene edited NK cell-based therapeutic strategies

Benjamin H. Goldenson, Dan S. Kaufman

Summary: The study demonstrates that expression of modified CD16a and IL-15 receptor combined with knockout of CD38 can enhance NK cell-mediated activity against leukemia and multiple myeloma.

CELL STEM CELL (2021)

Article Allergy

Disease-associated mutations in topoisomerase II? result in defective NK cells

Lori Broderick, Gwendolyn M. Clay, Robert H. Blum, Yang Liu, Rachael McVicar, Fabio Papes, Laela M. Booshehri, Ian G. Cowell, Caroline A. Austin, Christopher D. Putnam, Dan S. Kaufman

Summary: The study examines the impact of Hoffman syndrome-associated mutations in TOP2B on the development and function of NK cells. Using a knockin murine model and patient-derived iPSCs, the researchers investigated NK-cell development in mouse bone marrow and spleen, and assessed the immunophenotype, gene expression, and cytotoxic activity of NK cells in both murine and human models.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2022)

Article Cell & Tissue Engineering

Human induced pluripotent stem cell-derived macrophages ameliorate liver fibrosis

Somayeh Pouyanfard, Nairika Meshgin, Luisjesus S. Cruz, Karin Diggle, Hamidreza Hashemi, Timothy Pham, Manuel Fierro, Pablo Tamayo, Andrea Fanjul, Tatiana Kisseleva, Dan S. Kaufman

Summary: The study shows that human iPSC-derived macrophages can effectively reduce gene expression and pathological markers of liver fibrosis, offering a promising cell therapy approach to ameliorate fibrosis.

STEM CELLS (2021)

Article Cell Biology

iPSC-derived NK cells maintain high cytotoxicity and enhance in vivo tumor control in concert with T cells and anti-PD-1 therapy

Frank Cichocki, Ryan Bjordahl, Svetlana Gaidarova, Sajid Mahmood, Ramzey Abujarour, Hongbo Wang, Katie Tuininga, Martin Felices, Zachary B. Davis, Laura Bendzick, Raedun Clarke, Laurel Stokely, Paul Rogers, Moyar Ge, Megan Robinson, Betsy Rezner, David L. Robbins, Tom T. Lee, Dan S. Kaufman, Bruce R. Blazar, Bahram Valamehr, Jeffrey S. Miller

SCIENCE TRANSLATIONAL MEDICINE (2020)

No Data Available